CorMedix (CRMD) Financial Statements & Analysis

CorMedix (CRMD) Income Statement

CorMedix reported revenue of $311.71M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 617.0% from $43.47M a year earlier. Net income was $163.06M, a net margin of 52.3%. Gross margin was 88.5% and operating margin 48.2%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $99.31M, up 149.9% from the same quarter a year earlier.

CorMedix Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

CorMedix Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	311.71	43.47	0.00	0.07	0.19	0.24	0.28	0.43	0.33
Cost of Revenue	35.96	3.19	0.21	0.00	0.15	0.20	0.37	0.40	0.11
Gross Profit	275.75	40.28	-0.21	0.06	0.04	0.03	-0.09	0.03	0.21
Operating Expenses
Research & Development	19.33	3.94	13.16	10.68	13.13	13.38	11.05	18.82	24.49
Selling, General & Administrative	30.17	58.70	35.80	20.01	16.35	13.88	0.00	8.07	8.65
Operating Expenses	125.61	62.64	48.75	30.69	29.48	27.26	20.92	26.90	33.14
Operating Income	150.14	-22.36	-48.96	-30.62	-29.44	-27.22	-21.01	-26.86	-32.92
Other Income/Expense
Interest Income	3.85	2.58	2.68	0.33	0.01	0.12	0.32	0.04	0.11
Interest Expense	2.78	0.04	0.03	0.03	0.02	-0.03	0.79	0.00	0.01
Other Income/Expense	-0.13	0.49	2.62	0.34	-0.02	0.02	9.64	0.03	-0.09
Income
Income Before Tax	150.02	-19.33	-46.34	-30.29	-29.46	-27.20	-11.37	-26.83	-33.01
Income Tax Expense	-13.04	-1.40	0.00	-0.59	-1.25	-5.17	5.06	0.04	-0.03
Net Income	163.06	-17.93	-46.34	-29.70	-28.21	-22.03	-16.43	-26.83	-33.01
Net Income - Continuous Operations	163.06	-17.93	-46.34	-29.70	-28.21	-22.03	-16.43	-26.83	-33.01
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-
EBITDA	167.79	-18.98	-46.23	-30.05	-29.38	-27.09	-20.93	-26.75	-32.97
EBIT	152.80	-19.29	-48.96	-30.62	-29.44	-27.22	-	-	-
Depreciation & Amortization	14.99	0.31	0.07	0.21	0.06	0.13	0.07	0.07	0.04
Earnings Per Share
Basic EPS	2.00	-	-1.00	-1.00	-1.00	-1.00	-1.00	-2.00	-3.00
Diluted EPS	2.00	-	-1.00	-1.00	-1.00	-1.00	-1.00	-2.00	-3.00
Basic Shares Outstanding	72.03	58.87	50.90	40.14	37.67	28.56	24.15	17.82	11.03
Diluted Shares Outstanding	80.31	58.87	50.90	40.27	37.67	28.56	24.15	17.82	11.03

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About CorMedix Financial Statements

What was CorMedix's revenue in fiscal 2025?

CorMedix reported revenue of $311.71M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 617.0% from $43.47M a year earlier.

Is CorMedix profitable?

Yes. CorMedix earned net income of $163.06M in fiscal 2025, a net margin of 52.3%. In fiscal 2024 it lost $17.93M.

What is CorMedix's operating margin?

CorMedix's operating income was $150.14M on revenue of $311.71M in fiscal 2025, an operating margin of 48.2%, compared with -51.4% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition